Why the study?
Is the LPL H-X447 haplotype associated with a lower risk of premature myocardial infarction and lower plasma triglycerides compared to the H+S447 haplotype?
Population
2,119 subjects from the European Atherosclerosis Research Study from five regions of Europe.
Comparison
LPL gene variation (H-X447 haplotype) vs H+S447 haplotype
Design
Case-control
Authors
Loading...
No change to clinical MI risk assessment; leaves open whether LPL H-X447 variants causally modify familial cardiovascular risk.
Is the LPL H-X447 haplotype associated with a lower risk of premature myocardial infarction and lower plasma triglycerides compared to the H+S447 haplotype?
The LPL H-X447 haplotype is associated with a reduced risk of premature myocardial infarction and lower fasting and postprandial triglyceride levels.
Humphries et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: